Topical Chemoprevention of Skin Cancer Biomarkers

NCT02636569 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Non-melanoma Skin Cancer

Interventions

DRUG: topical diclofenac daily
DRUG: placebo

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]
[object Object]